Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Remke

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Developmental Cell|September 30, 2014
The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumorsFrédéric Mille, Lukas Tamayo-Orrego, Martin Lévesque, et al.
Cancers|July 9, 2022
WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like CellsSuad Yusuf, Philippe Aretz, Ann-Christin Nickel, et al.
Journal of Neuro-Oncology|July 10, 2012
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysisAndré O von Bueren, Joachim Gerss, Christian Hagel, et al.
Haematologica|August 11, 2018
The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cellsDeborah Ingenhag, Sven Reister, Franziska Auer, et al.
Oncotarget|October 27, 2015
Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypesLisa Liang, Christopher Aiken, Robyn McClelland, et al.
Scientific Reports|April 30, 2020
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaBritta Tjaden, Katharina Baum, Viktoria Marquardt, et al.
EMBO Molecular Medicine|August 22, 2022
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancerTherese Seidlitz, Tim Schmäche, Fernando Garcίa, et al.
Genes, Chromosomes & Cancer|June 27, 2007
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomasStefan Pfister, Marc Remke, Grischa Toedt, et al.
Acta Neuropathologica Communications|November 21, 2013
G-protein coupled receptor expression patterns delineate medulloblastoma subgroupsKelsey L Whittier, Erin A Boese, Katherine N Gibson-Corley, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2022
CD155 is a putative therapeutic target in medulloblastomaSean Li, Roger McLendon, Eric Sankey, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Developmental Cell|September 30, 2014
The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumorsFrédéric Mille, Lukas Tamayo-Orrego, Martin Lévesque, et al.
Cancers|July 9, 2022
WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like CellsSuad Yusuf, Philippe Aretz, Ann-Christin Nickel, et al.
Journal of Neuro-Oncology|July 10, 2012
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysisAndré O von Bueren, Joachim Gerss, Christian Hagel, et al.
Haematologica|August 11, 2018
The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cellsDeborah Ingenhag, Sven Reister, Franziska Auer, et al.
Oncotarget|October 27, 2015
Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypesLisa Liang, Christopher Aiken, Robyn McClelland, et al.
Scientific Reports|April 30, 2020
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaBritta Tjaden, Katharina Baum, Viktoria Marquardt, et al.
EMBO Molecular Medicine|August 22, 2022
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancerTherese Seidlitz, Tim Schmäche, Fernando Garcίa, et al.
Genes, Chromosomes & Cancer|June 27, 2007
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomasStefan Pfister, Marc Remke, Grischa Toedt, et al.
Acta Neuropathologica Communications|November 21, 2013
G-protein coupled receptor expression patterns delineate medulloblastoma subgroupsKelsey L Whittier, Erin A Boese, Katherine N Gibson-Corley, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2022
CD155 is a putative therapeutic target in medulloblastomaSean Li, Roger McLendon, Eric Sankey, et al.
Pageof 19